Neurology and Alzheimer’s Disease Research

At Brain Research Center Zwolle B.V., the strongest focus is on nervous system diseases, especially Alzheimer’s disease and related forms of cognitive decline. The trials are designed to test new treatment options, assess symptom improvement, and better understand how therapies may affect memory and daily functioning in people with early and mild to moderate disease.

  • Early and mild to moderate Alzheimer’s disease
  • Cognitive impairment and decline in thinking skills
  • Testing new therapies to slow disease progression and improve function

Several studies also look at biomarkers and brain changes, helping researchers evaluate whether treatments are affecting the underlying disease process.

Parkinson’s Disease and Movement Disorders

The site is also active in neurology research for Parkinson’s disease, including early-stage disease. These trials aim to evaluate whether investigational treatments can slow progression, preserve motor function, and support long-term disease control.

  • Early-stage Parkinson’s disease
  • Measuring treatment effectiveness in slowing progression
  • Exploring new options for disease modification

This work reflects a broader effort in nervous system diseases to find therapies that may change the course of chronic neurodegenerative illness.

Cardiovascular and Metabolic Disease Studies

Research at this laboratory and testing facility also includes cardiovascular diseases and nutritional and metabolic diseases. Current trials focus on reducing the risk of heart failure and cardiovascular death, while also studying conditions linked to type 2 diabetes, hypertension, and established cardiovascular disease.

  • Heart failure prevention and risk reduction
  • Type 2 diabetes with cardiovascular complications
  • Evaluating new combinations to improve cardiovascular outcomes

These studies aim to improve treatment effectiveness for people with overlapping metabolic and heart-related conditions.

Brain Health, Biomarkers, and Related Disorders

The Zwolle site contributes to research on how brain diseases can be tracked and treated more precisely, including studies in mental disorders and broader nervous system diseases. A number of trials examine biomarkers, imaging findings, and clinical progression to support earlier diagnosis and more targeted care.

  • Investigating biomarkers linked to Alzheimer’s disease progression
  • Using brain imaging to monitor treatment effects
  • Supporting earlier and more accurate disease assessment

This research helps connect clinical symptoms with biological changes, offering a clearer picture of how different therapies may work in practice.